4//SEC Filing
Regnante Keith 4
Accession 0001415889-25-004597
CIK 0001664710other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:15 PM ET
Size
5.0 KB
Accession
0001415889-25-004597
Insider Transaction Report
Form 4
Regnante Keith
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2025-02-18+44,000→ 44,000 total
Footnotes (1)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs vest as follows: 33% of the RSUs shall vest on February 17, 2026, an additional 34% of the total number of RSUs shall vest on August 15, 2026, and the remaining 33% of the total number of RSUs shall vest on February 16, 2027, in each case, subject to the Reporting Person's Continuous Service (as defined in the 2020 Plan) through each applicable vesting date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001682068
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:15 PM ET
- Size
- 5.0 KB